Bridgewater Associates LP Has $2.50 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bridgewater Associates LP decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 43.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 32,019 shares of the company’s stock after selling 24,558 shares during the quarter. Bridgewater Associates LP’s holdings in GE HealthCare Technologies were worth $2,503,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Cathy Pareto & Associates Inc. acquired a new position in GE HealthCare Technologies during the fourth quarter valued at approximately $670,000. Principal Financial Group Inc. lifted its stake in GE HealthCare Technologies by 1.9% in the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after buying an additional 19,010 shares in the last quarter. Everence Capital Management Inc. boosted its holdings in shares of GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock valued at $1,475,000 after buying an additional 10,220 shares during the period. Apollon Wealth Management LLC increased its position in shares of GE HealthCare Technologies by 46.5% during the fourth quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company’s stock worth $1,025,000 after acquiring an additional 4,160 shares in the last quarter. Finally, Sanibel Captiva Trust Company Inc. raised its holdings in shares of GE HealthCare Technologies by 139.9% during the fourth quarter. Sanibel Captiva Trust Company Inc. now owns 7,484 shares of the company’s stock worth $585,000 after acquiring an additional 4,364 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on GEHC shares. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price objective for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the company a “buy” rating in a research note on Monday. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $97.27.

GE HealthCare Technologies Stock Up 1.4 %

GE HealthCare Technologies stock opened at $62.37 on Friday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a 50 day moving average price of $79.26 and a two-hundred day moving average price of $83.09. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The firm has a market cap of $28.56 billion, a price-to-earnings ratio of 14.40, a PEG ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.22%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.